The owner of a nightclub connected to a serious meningitis outbreak in Canterbury has publicly addressed the situation, as health authorities issue an urgent call for preventative treatment. Louise Jones-Roberts, proprietor of Club Chemistry, expressed deep concern and devastation following the incident, which has resulted in two confirmed deaths from the illness.
Urgent Health Advisory Issued by UKHSA
The UK Health Security Agency (UKHSA) has formally advised anyone who attended Club Chemistry between March 5 and March 7 to immediately come forward for preventative antibiotic treatment. This directive aims to contain the spread of the bacterial infection, which can lead to severe complications, including meningitis.
Nightclub Owner's Response and Actions
Louise Jones-Roberts revealed that over 2,000 individuals likely visited the venue during the critical three-day period. In response to the outbreak, she has proactively contacted approximately 90 out of 95 staff members, all of whom have since received antibiotics as a precautionary measure.
The nightclub will remain closed indefinitely until further notice, a decision Ms. Jones-Roberts emphasized was made to prioritize public safety. She stated that had she been aware of early symptoms among patrons, she would not have opened the venue last weekend, underscoring her worry about a potential secondary outbreak.
Emotional Impact and Community Concerns
"I'm devastated for the families affected. It's so incredibly sad," Ms. Jones-Roberts said, adding, "I just really hope people know the symptoms and no more lives are lost." Her comments highlight the emotional toll on the local community, particularly among students at the University of Kent, where queues have formed for antibiotic distribution.
The situation has sparked heightened awareness about meningitis symptoms, such as fever, headache, and neck stiffness, with health officials urging vigilance. The UKHSA continues to monitor the outbreak closely, coordinating with local healthcare providers to ensure accessible treatment for those at risk.
